| Literature DB >> 32245525 |
Ariel Jaffe1, Joseph K Lim2, Sofia Simona Jakab3.
Abstract
Hepatic encephalopathy (HE) is one of the major clinical decompensations of cirrhosis, with a high impact on health care resource utilization and cost. For an effective and comprehensive management of HE, the clinicians need to understand the pathophysiologic mechanisms of HE. This review describes the multiorgan processes involved in HE and how several HE precipitants and treatment strategies act on ammonia production, excretion, and neurotoxicity, including the impact of diabetes and use of cannabinoids. The authors also discuss the current and future role of gut microbiome, systemic/central inflammation, and various neurotransmitters for the pathogenesis and treatment of HE. Published by Elsevier Inc.Entities:
Keywords: Ammonia; Cannabinoids; Gut-liver-brain axis; Hepatic encephalopathy; Liver cirrhosis; Neurotoxicity; Neurotransmitters; TNF-Alpha
Mesh:
Substances:
Year: 2020 PMID: 32245525 DOI: 10.1016/j.cld.2020.01.002
Source DB: PubMed Journal: Clin Liver Dis ISSN: 1089-3261 Impact factor: 6.126